The University of Manchester's Centre of Excellence in Biopharmaceuticals (COEBP) has developed a biopharmaceutical manufacturing platform that allows rapid isolation of high-producing CHO cell ...

Chinese hamster ovary (CHO) cells have become one of the most popular cell type for recombinant antibody production – for good reason. CHO cells meet several key requirements for industrial scale ...

Scientists have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, ...

To permanently access this App Note for free, fill out the short form below. The isolation and expansion of rare and ultra-rare cell populations are important for advancing cell therapy manufacturing.

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Therapeutic proteins play a crucial role in the biological pharmaceutical sector, serving as treatment options for diseases such as diabetes, cancer, and anemia. In recombinant protein development, a ...

Many increasingly used applications, such as cell line engineering and sequencing (including ATAC-seq and RNA-seq) along with single-cell genomics, require single-cell isolation as a starting point.